These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37585628)

  • 1. Gene Therapy in Patients with the Crigler-Najjar Syndrome.
    D'Antiga L; Beuers U; Ronzitti G; Brunetti-Pierri N; Baumann U; Di Giorgio A; Aronson S; Hubert A; Romano R; Junge N; Bosma P; Bortolussi G; Muro AF; Soumoudronga RF; Veron P; Collaud F; Knuchel-Legendre N; Labrune P; Mingozzi F
    N Engl J Med; 2023 Aug; 389(7):620-631. PubMed ID: 37585628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV8 Gene Therapy Rescues the Newborn Phenotype of a Mouse Model of Crigler-Najjar.
    Greig JA; Nordin JML; Draper C; Bell P; Wilson JM
    Hum Gene Ther; 2018 Jul; 29(7):763-770. PubMed ID: 29448836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained reduction of hyperbilirubinemia in Gunn rats after adeno-associated virus-mediated gene transfer of bilirubin UDP-glucuronosyltransferase isozyme 1A1 to skeletal muscle.
    Pastore N; Nusco E; Vaníkova J; Sepe RM; Vetrini F; McDonagh A; Auricchio A; Vitek L; Brunetti-Pierri N
    Hum Gene Ther; 2012 Oct; 23(10):1082-9. PubMed ID: 22765254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gilbert or Crigler-Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity.
    Cozzi L; Nuti F; Degrassi I; Civeriati D; Paolella G; Nebbia G
    Ital J Pediatr; 2022 Apr; 48(1):59. PubMed ID: 35436954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome.
    Aronson SJ; Veron P; Collaud F; Hubert A; Delahais V; Honnet G; de Knegt RJ; Junge N; Baumann U; Di Giorgio A; D'Antiga L; Ginocchio VM; Brunetti-Pierri N; Labrune P; Beuers U; Bosma PJ; Mingozzi F
    Hum Gene Ther; 2019 Oct; 30(10):1297-1305. PubMed ID: 31502485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer.
    Bortolussi G; Zentilin L; Baj G; Giraudi P; Bellarosa C; Giacca M; Tiribelli C; Muro AF
    FASEB J; 2012 Mar; 26(3):1052-63. PubMed ID: 22094718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia.
    Montenegro-Miranda PS; Sneitz N; de Waart DR; Ten Bloemendaal L; Duijst S; de Knegt RJ; Beuers U; Finel M; Bosma PJ
    Biochim Biophys Acta; 2012 Aug; 1822(8):1223-9. PubMed ID: 22546842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease burden of Crigler-Najjar syndrome: Systematic review and future perspectives.
    Dhawan A; Lawlor MW; Mazariegos GV; McKiernan P; Squires JE; Strauss KA; Gupta D; James E; Prasad S
    J Gastroenterol Hepatol; 2020 Apr; 35(4):530-543. PubMed ID: 31495946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats.
    Jia Z; Dankó I
    Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome.
    Bortolussi G; Zentillin L; Vaníkova J; Bockor L; Bellarosa C; Mancarella A; Vianello E; Tiribelli C; Giacca M; Vitek L; Muro AF
    Hum Gene Ther; 2014 Sep; 25(9):844-55. PubMed ID: 25072305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.
    Kadakol A; Ghosh SS; Sappal BS; Sharma G; Chowdhury JR; Chowdhury NR
    Hum Mutat; 2000 Oct; 16(4):297-306. PubMed ID: 11013440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of Crigler-Najjar syndrome type I: long survival with bilirubin adsorption and liver transplantation].
    Shimizu N; Mizutani M; Aoki T
    No To Hattatsu; 2005 Jul; 37(4):337-41. PubMed ID: 16026101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats.
    Schmitt F; Remy S; Dariel A; Flageul M; Pichard V; Boni S; Usal C; Myara A; Laplanche S; Anegon I; Labrune P; Podevin G; Ferry N; Nguyen TH
    Gastroenterology; 2010 Sep; 139(3):999-1007, 1007.e1-2. PubMed ID: 20546738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.
    Maruo Y; Nakahara S; Yanagi T; Nomura A; Mimura Y; Matsui K; Sato H; Takeuchi Y
    J Gastroenterol Hepatol; 2016 Feb; 31(2):403-8. PubMed ID: 26250421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.
    Askari FK; Hitomi Y; Mao M; Wilson JM
    Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type I Crigler Najjar syndrome in Tunisia: a study of 30 cases].
    Aloulou H; Ben Thabet A; Khanfir S; Ben Mansour L; Chabchoub I; Labrune P; Kammoun T; Hachicha M
    Tunis Med; 2010 Oct; 88(10):707-9. PubMed ID: 20890816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector.
    van der Wegen P; Louwen R; Imam AM; Buijs-Offerman RM; Sinaasappel M; Grosveld F; Scholte BJ
    Mol Ther; 2006 Feb; 13(2):374-81. PubMed ID: 16337205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.
    Strauss KA; Ahlfors CE; Soltys K; Mazareigos GV; Young M; Bowser LE; Fox MD; Squires JE; McKiernan P; Brigatti KW; Puffenberger EG; Carson VJ; Vreman HJ
    Hepatology; 2020 Jun; 71(6):1923-1939. PubMed ID: 31553814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1.
    Li Q; Murphree SS; Willer SS; Bolli R; French BA
    Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthotopic liver transplantation for type I Crigler-Najjar syndrome.
    Kaufman SS; Wood RP; Shaw BW; Markin RS; Rosenthal P; Gridelli B; Vanderhoof JA
    Hepatology; 1986; 6(6):1259-62. PubMed ID: 3098664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.